American Association for Cancer Research (AACR)

Coronavirus Information and Resources: Learn how the COVID-19 pandemic has created special challenges for cancer patients, survivors, and their families.

Learn More

Survivor Journeys

Read inspiring stories from survivors benefiting from research-driven advances against cancer, like colon cancer survivor Bob Ribbans of Ringoes, New Jersey.

Read Bob’s Story

Cancer Today

Cancer Treatment During a Pandemic: People being treated for cancer may be at elevated risk of developing severe cases of COVID-19. The coronavirus is also affecting how cancer care is delivered.

Cancer Types

More than 17,500 people a year in the U.S. are diagnosed with esophageal cancer. Learn more about this type of cancer including the prevention, screening, and treatment options.

Learn More

FDA Approvals

Read about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.

Learn More

Get Involved

Join the AACR Runners for Research for virtual runs this spring and summer to stay active and help raise critically needed funds for lifesaving cancer research.

Learn More

For Researchers

AACR Annual Meeting

Meeting to Be Held in Virtual Format Only
Due to the rapid escalation of the COVID-19 pandemic, the AACR Board of Directors made the decision not to move forward with an in-person Annual Meeting in August, and instead to present segments of the meeting program in two AACR Virtual Annual Meetings.

Learn More

Videos

Driving Progress Against Cancer

The American Association for Cancer Research (AACR) and our more than 44,000 members worldwide are advancing a scientifically bold agenda against the collection of devastating diseases we call cancer.

Keeping Breast Cancer at Bay with Immunotherapy

Eva was devastated to learn her triple-negative breast cancer had spread to her lungs and sternum, but immunotherapy has allowed her and her husband to enjoy retirement together.

Charles L. Sawyers, MD: Fellow of the AACR Academy

A physician-scientist and leader in the development of targeted therapies for cancer, Dr. Sawyers investigates the signaling pathways that drive the growth and drug resistance of cancer cells.